SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001070081-18-000020
Filing Date
2018-01-05
Accepted
2018-01-05 16:11:04
Documents
2
Period of Report
2018-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151518665065551.html 4  
1 FORM 4 wf-form4_151518665065551.xml 4 3854
2 POWER OF ATTORNEY - SCHMERTZLER ex-24.htm EX-24 4071
  Complete submission text file 0001070081-18-000020.txt   9357
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1300 VALLEY ROAD NEW CANAAN CT 06840
Business Address
SCHMERTZLER MICHAEL (Reporting) CIK: 0001288952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 18513533